Jonathan Kentley, MBBS, MSc, research fellow at Memorial Sloan Kettering Cancer Center, explains ways artificial intelligence (AI) is being used in dermatology, including smartphone applications, at the 2022 American Academy of Dermatology Annual Meeting.
Jonathan Kentley, MBBS, MSc, research fellow at Memorial Sloan Kettering Cancer Center, highlights the ways artificial intelligence (AI) is being used in dermatology, including smartphone applications.
Transcript
How is AI being used in dermatology?
It's a super exciting time in dermatology and medicine, as artificial intelligence is really coming to the forefront of the way that we're going to practice medicine. Really, the bulk of the research has been on identification of melanoma from images, and there's been a number of papers since 2017 showing that artificial intelligence algorithms are as good or better than dermatologists at interpreting pigmented lesions. Also, this stands for other skin cancers and there's more and more research being published in that area. Even though it's in its infancy, there is more research now into inflammatory skin disease like acne, rosacea, eczema, and psoriasis, so it's a very exciting time. In Europe, there's a few apps and algorithms that now have CE mark, but in dermatology, nothing is yet FDA approved, so anything that's being done at the moment is very much experimental in research.
How are smartphone apps that use AI helping to diagnose and treat dermatological conditions?
I actually did some research recently on smartphone apps. We scoured the Apple App Store, Google Play Store, as well as Google desktop, and actually there's a huge amount of dermatology apps out there, but extremely unregulated. As I mentioned earlier, there's only really 3 that have a CE mark in Europe, whereas the rest are being sort of sold under the guise of being a research tool of education. It's really important that there's a lot more jurisdiction and regulation of the apps that are out there. Beyond skin cancer, there are some proprietary apps that look at acne and suggest topical treatments for acne. Quite interestingly, there are some apps and imaging software that will allow us to do PASI [Psoriasis Area and Severity Index] and EASI [Eczema Area and Severity Index] scoring, which will make it a much better, more objective method of scoring patients.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More